Ying Pharmaceutical Industry-B (07630.HK) will conduct a public offering from May 5th to May 8th, intending to globally sell 41.977 million H shares.

Wisdom Financial News APP reported that Yingpai Pharmaceutical -B (07630.HK) will be listed from May 5, 2026 to May 8, 2026. The company plans to globally issue 41.977 million H shares, with approximately 10% for public offering in Hong Kong, approximately 90% for international offering, and an additional 15% for over-allotment option. The offer price is set at HK$19.75-21.75 per share. Each board lot consists of 200 H shares, and trading of H shares is expected to begin at 9:00 AM on May 13, 2026 (Wednesday) on the Hong Kong Stock Exchange.